BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2018
View Archived Issues
Series A financing to support Modis' development of MT-1621 for thymidine kinase 2 deficiency
Read More
Gallium has antibiotic properties and improves lung function in humans with chronic lung infections
Read More
Researchers link FCN3 to mortality in patients with type 1 diabetes
Read More
Mutations in RIPPLY3 gene cause conotruncal heart defects in Han Chinese
Read More
Knockout of HRD1 protects mice from high fat diet-induced obesity
Read More
CXCL14 downregulation as novel therapeutic strategy in type 2 diabetes
Read More
CD44 as novel therapeutic target in diabetes
Read More
Researchers identify Lrrc55 as potential new target in pancreatic beta cells
Read More
A Finnish founder mutation in junctophilin-2 causes hypertrophic cardiomyopathy
Read More
Humira goes to Stockholm: Three win Chemistry Nobels for protein engineering methods
Read More
Go Therapeutics and Roche enter license agreement to develop glycotargeting bispecific antibody
Read More
OncoTherapy Science patents SUV39H2 inhibitors
Read More
Encouraging initial data presented from two ongoing studies of Trappsol Cyclo in NPC
Read More
Pfizer identifies LRRK2 inhibitors
Read More
Yogee's Bioinnovations discloses cathepsin D and angiogenesis inhibitors
Read More
French researchers patent new beta-lactamase inhibitors
Read More
Theravance Biopharma divulges JAK inhibitors
Read More
Jiangsu Alphamab initiates first-in-human trial of KN-026 for advanced breast and gastric cancer
Read More
Boston expands pipeline through licensing deals with Novartis and GSK
Read More
Que Oncology opens phase II trial of Q-122 to treat vasomotor symptoms in breast cancer patients
Read More
Eagle enters agreement with USAMRICD to evaluate neuroprotective effects of Ryanodex
Read More
Medivir reports phase I data from ongoing study of birinapant with Keytruda in advanced solid tumors
Read More
VE-303 results in accelerated gut microbiota restoration after antibiotics in phase I study
Read More
Eisai studies E-2730 in adults with photosensitive epilepsy
Read More
Tumor-specific peptide-conjugated siRNA targeting CDCA1 effectively treats prostate cancer in mice
Read More